Hematology CME Courses

Hematology CME Courses

Format: Online Streaming Video
Price: Free
Release Date: May 12, 2016
Expiration Date: May 12, 2018
Summary:

Acute lymphoblastic leukemia (ALL) is one of a group of malignancies caused by cytogenetic DNA mutations of developing hematopoietic stem cell precursors and mostly common to children with peak incidence at 2-5 years of age. Although approximately 80% of ALL cases present in children, they also occur in adults.  The symptoms of ALL are non-specific and similar to those of acute myelogenous leukemia (AML), which patients usually have 1-3 months of complaints.

By the end of the session the participant will be able to:

  • Summarize the most impactful findings presented at ASH 2015 relating to ALL and apply them to patient cases, taking into account any relevant barriers to care.
  • Additional objectives to be dictated by clinical content
Format: Interactive Online, Online Streaming Video, PDF
Price: Free
Release Date: November 02, 2017
Expiration Date: November 02, 2019
Summary:

Multiple myeloma (MM) is a hematologic malignancy of the lymphocytes. All cases are marked by monoclonal gammopathy, and while the true cause is unknown, associated factors are thought to include: radiation, genetics, viral infections, and the human immunodeficiency virus. Helping the clinician discern the role of each of the first-line and more novel therapies, including monoclonal antibodies and proteasome, deacetylase, and 3 serine/threonine protein kinase inhibitor therapies – among others – based on the most up-to-date research merits continuing education programming in MM.

By the end of the session the participant will be able to:

  • Recall updates in the staging, prognosis, and diagnosis of MM.
  • Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
  • Distinguish between the most appropriate treatment approaches to MM and apply them to practice, taking into account the following: evidence-based treatment guidelines, algorithms, and expert opinion.
  • Summarize the risk-benefit profiles of current and emerging therapies for the treatment of MM.
Format: Online Streaming Video
Price: $895
Release Date: 8/1/2015
Expiration Date: 8/1/2018
Summary: The Comprehensive Review of Blood Banking was developed to offer knowledge concerning demands and responsibilities of pathologists in evaluating and understanding immunohematology lab tests and deciding on correct use of blood components. This course discusses the imperative need to understand the expectations and observe guidelines in dealing with daily transfusion medicine. In this course, presentors will discuss the latest information on blood group serology and molecular advancements, in addition to patient blood management with fact based utilization decisions. Lecturers will describe not only the use blood components, but also the safe and correct use of blood derived factors and Rh Immunoglobin for transfusion medicine. Vital problems and potential complications in blood component use will be discussed together with the present consensus recommendations for safe transfusion. The program provides contemporary knowledge and practical guidelines for pathologists dealing with transfusion medicine. Attendees will benefit from this course by comparing, reviewing, modifying, and improving their own practice and applying new information to their daily work.
Format: Audio CD, DVD, MP3, MP4, Online Streaming Video
Price: $1,295 - $1,895
Release Date: 6/30/2016
Expiration Date: 6/30/2019
Summary: The Brigham Board Review in Hematology was developed to provide Hematology fellows/trainees, Hematologists/Oncologists, and internists with contemporary knowledge and management strategies in order to better care for their patients, in addition to helping to prepare candidates for the ABIM exam in Hematology.
Format: Audio CD, DVD, MP3, MP4, Online Streaming Video
Price: $1,795 - $2,695
Release Date: 6/30/2016
Expiration Date: 6/30/2019
Summary: The Brigham Board Review in Hematology and Oncology is designed to provide Hematology-Oncology fellows/trainees, Hematologists and Oncologists, and internists with new information and management strategies to further develop the care of their patients, in addition to preparing candidates for the ABIM exam in Hematology-Oncology.

Share This